Related Experiment Video
Updated: Mar 10, 2026

11:15
Nanosponge Tunability in Size and Crosslinking Density
Published on: August 4, 2017
8.2K
Chitosan-coupled solid lipid nanoparticles: Tuning nanostructure and mucoadhesion.
Giuseppina Sandri1, Simona Motta2, Maria Cristina Bonferoni1
1Dept of Drug Sciences, University of Pavia, Via Taramelli, 12, 27100 Pavia, Italy.
Summary
New chitosan-associated solid lipid nanoparticles (CS-SLNs) offer enhanced mucoadhesion for ophthalmic drug delivery. This one-step method creates stronger chitosan-SLN interactions, improving precorneal residence time.
Area of Science:
- Nanotechnology
- Materials Science
- Ophthalmology
Background:
- Solid Lipid Nanoparticles (SLNs) are promising for drug delivery, especially in ophthalmic applications.
- Chitosan association aims to improve SLN precorneal residence time via mucoadhesion.
Purpose of the Study:
- To develop and characterize novel chitosan-associated SLNs (CS-SLNs) using a one-step preparation method.
- To evaluate the interaction strength between chitosan and SLNs compared to traditional coating methods.
Main Methods:
- A one-step protocol for CS-SLN preparation.
- Characterization using light, neutron, and X-ray scattering, Zeta-potential, Atomic Force Microscopy (AFM), and calorimetry.
- Comparison with chitosan-free and chitosan-coated SLNs.
Main Results:
- The one-step method yielded CS-SLNs with strong, intimate chitosan-SLN interactions, superior to simple coating.
- Nanoparticles maintained nano-size and surface charge suitable for drug vectors.
- CS-SLNs demonstrated improved mucoadhesion properties.
Conclusions:
- The one-step preparation offers an efficient route to CS-SLNs with enhanced mucoadhesion.
- These CS-SLNs show potential for high-performing ophthalmic drug delivery formulations.
- Stronger chitosan-SLN coupling is key to improved precorneal residence time.
Related Concept Videos
Bioavailability Enhancement: Drug Solubility Enhancement
399
Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
399
Micelles
96
Micelle formation is an intricate process that hinges on the properties of amphiphilic or amphipathic molecules and the conditions of the system in which they are found. Amphiphilic molecules, which have both hydrophilic (water-attracting) and hydrophobic (water-repelling) parts, play a critical role in this process.In aqueous environments, these molecules arrange themselves such that their hydrophilic heads are turned towards the water phase, while their hydrophobic tails are oriented away...
96
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
289
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
289
Bioavailability Enhancement: Drug Permeability Enhancement
283
After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt secretion,...
283

